Oxford Drug Design
Oxford
About Oxford Drug Design
InhibOx is a pioneer in the development and application of new technologies to drive drug discovery. Their multidisciplinary research team has brought together breakthroughs in computational chemistry, cheminformatics, mathematics, cloud computing and software-as-a-service (SaaS) delivery methods to create DrugFinder: the next generation drug discovery platform.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $12.5M
- Last round: Grant (Feb 2025)
- Website: oxforddrugdesign.com
- Phone: 441865261471
Industries & Categories
Biotechnology, Delivery, SaaS, Software
Social Profiles
Canonical: https://fsome.com/organization/oxford-drug-design-87104 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.